Kim, T., Park, B., Heo, S., Jeon, H., Kim, J., Kim, D., . . . Lu, T. Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer. eLife Sciences Publications Ltd.
Chicago Style (17th ed.) CitationKim, Tackhoon, et al. Combinatorial CRISPR Screen Reveals FYN and KDM4 as Targets for Synergistic Drug Combination for Treating Triple Negative Breast Cancer. eLife Sciences Publications Ltd.
MLA (9th ed.) CitationKim, Tackhoon, et al. Combinatorial CRISPR Screen Reveals FYN and KDM4 as Targets for Synergistic Drug Combination for Treating Triple Negative Breast Cancer. eLife Sciences Publications Ltd.
Warning: These citations may not always be 100% accurate.